Mr Myles Smith and colleagues at The Melanoma Unit, The Royal Marsden Hospital NHS Foundation Trust, UK, recently published an article entitled ‘The impact of effective systemic therapies on surgery for stage IV melanoma’ in the European Journal of Cancer.
Outcomes of patients with metastatic melanoma have been positively impacted by the introduction of effective systemic treatments (EST) such as immunotherapy. Surgery for metastatic melanoma has evolved, and may still play an important role in improving outcomes in carefully selected cases.
